ALS News Today2d
Qalsody approved in Canada for ALS tied to SOD1 mutations
Health regulators in Canada gave conditionally approval to Qalsody to treat adults whose ALS is due to mutations in the SOD1 ...
QALSODY™ (tofersen injection) Receives Conditional Marketing Authorization from Health Canada as the First ALS Treatment Targeting a Genetic Cause
Biogen Canada Inc. announced today that Health Canada has issued marketing authorization with conditions (Notice of Compliance with Conditions (NOC/c)) for QALSODY™ (tofersen injection) for the ...
pharmaphorum2d
Biogen gets FDA approval for ALS drug Qalsody
The drug – branded as Qalsody – is the first therapy to be approved for a genetic form of ALS, and is also notable for being the first neurology therapeutic for which a blood biomarker has ...
NBC 10 Philadelphia13d
How rising health care claim denials are hurting Americans
She fought her insurer, Blue Cross Blue Shield of Texas, to secure approval for Qalsody, which her doctors said was the most ...
WINK NEWS19d
Breakthrough for patients diagnosed with ALS
With more than a dozen cases in her family, they participated in a study that led to the drug Qalsody. “That’s when they were actually looking for the biomarkers so that they could develop the ...
Yahoo Finance15d
Ionis Pharmaceuticals, Inc. (IONS) Stock Forecasts
Ionis and Biogen brought Spinraza to market in 2016 as a treatment for spinal muscular atrophy, and Biogen launched ALS drug Qalsody in 2023. Ionis brought two additional drugs to market via its ...
NBC New York13d
How rising health care claim denials are hurting Americans
She fought her insurer, Blue Cross Blue Shield of Texas, to secure approval for Qalsody, which her doctors said was the most effective treatment for her form of ALS. "When we were first denied ...